Clade Therapeutics
Clade Therapeutics

Clade Therapeutics Information

Contact top employees from Clade Therapeutics

Summary

Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located in the heart of Cambridg...Show more

Industries

Biotechnology

Headquarters Location

Employees Size

100-200 employees

Founded

2020

Contact Clade Therapeutics

Organization Website

Social Links

linkedIn

Phone Number

415-886-7710

Competitors

Founded
Type
Employees
Revenue
Funding
2015Privately
Held
1 - 25 1.5M $49.5M
2017Privately
Held
25 - 100 < 1M $165M
2017Privately
Held
10-50 < 1M $3M
2018Privately
Held
100-200 < 1M $250M
-- 1-10 < 1M $0
-- 10-50 - $-

Employees Turnover 3 quarter 2025

Length of Employment
arrow
Employee tenure at Clade Therapeutics shows a diverse range of experience levels:
50% for 1–2 years43% for 3–4 years7% for 5–7 years
Contact top employees from Clade Therapeutics
Dar Heinze
Senior Scientist
View
Kathryn Austgen
Executive Director
View
Justin Fang
Principal Research Associate
View
Melissa Chin
Principal Research Associate
View
Anastasia Perris
Research Associate II, Molecular Immunology.
View
Krista Kauppinen
Associate General Counsel and Head, Intellectual Property
View
Emily Fagan
Senior Quality Control Specialist
View
Pamela Al Jarwani
Principal Specialist
View
Kristen Dettloff
Senior Research Associate, Cell Differentiation
View
Darren St John
Engineer II, Process Development
View
Leandro Vetcher
Chief Operating Officer
View
Mariana Mata
Senior Research Associate
View
Divyansi Pandey
Research Associate
View

FAQ

Clade Therapeutics operates in the Biotechnology industries. More details can be found on the official website: cladetx.com.
The headquarters of Clade Therapeutics are located in Boston, United States.
You can contact Clade Therapeutics by phone at 415-886-7710.
Clade Therapeutics currently employs 100-200 people.
Well-known competitors of Clade Therapeutics include Obsidian Therapeutics, Tango Therapeutics, Lucy Therapeutics and Redesign Health.
BACK TO TOP